Print Page

其 他 安 全 警 示

 
Canada: Reminding Canadians about using acetaminophen safely(English Only)
 
With the United States Food and Drug Administration (FDA) deciding to change dosage requirements for prescription acetaminophen combination products, Health Canada is reminding Canadians about using acetaminophen safely. Health Canada continues to review emerging and available safety evidence, including that used by the FDA to reach its decision and will determine if any new action may be needed to protect health and safety.

Please refer to the following website in Health Canada for details: http://www.hc-sc.gc.ca/ahc-asc/media/advisories-avis/_2011/2011_05-eng.php

In Hong Kong, there are ten products registered which contains paracetamol (another name of acetaminophen) in combination with opioids. Most of these products are prescription drugs. In light of the new labeling requirement of FDA, the issue will be considered in the coming meeting of the Registration Committee of Pharmacy and Poisons Board. Letter to inform healthcare professionals about FDA’s decision and remind them about using acetaminophen safely will be issued. In addition, any actions from other health authorities will be kept in view.



Ends/Friday, January 14, 2011
Issued at HKT 14:30
 
Related Information:
加拿大:讯息更新 – 加拿大卫生部提出对含扑热息痛的非处方产品的标签准则修订 上载于 2015-09-16
加拿大:加拿大卫生部采取新的行动以改善扑热息痛的安全,提醒加拿大人关于使用安全 上载于 2015-07-10
中国: 含对乙酰氨基酚的感冒药合理使用是安全的 上载于 2014-01-27
美国:药物安全通讯:扑热息痛处方产品的每剂量单位限制为325毫克 上载于 2014-01-15
The United States: FDA limits acetaminophen in prescription combination products... 上载于 2011-01-14
 
back